Press Releases

Investor Resources
Contact Us
Investor ResourcesPress Releases

Press Releases

Press Release Cardiol Therapeutics Announces First Patient Enrolled in ARCHER, a Phase II Clinical Trial of CardiolRx™ for Treatment of Acute MyocarditisAugust 3, 2022
Press Release Cardiol Therapeutics Reports Results of 2022 Annual General MeetingJune 29, 2022
Press Release Cardiol Therapeutics to Webcast Virtual Annual General Meeting on June 28th at 4:30 p.m. EDTJune 27, 2022
Press Release Cardiol Therapeutics Announces At-The-Market Equity Offering ProgramJune 9, 2022
Press Release Cardiol Therapeutics Appoints Teri Loxam and Chris Waddick to its Board of DirectorsMay 19, 2022
Press Release Cardiol Therapeutics Announces FDA Investigational New Drug Application (IND) Authorization for Multicenter Phase II Open-label Pilot Study of CardiolRx™ for Recurrent PericarditisMay 17, 2022
Press Release Cardiol Therapeutics Announces Year-End 2021 Update on OperationsMarch 24, 2022
Press Release Cardiol Therapeutics to Participate in Cantor Fitzgerald’s Virtual Rare Orphan Disease SummitMarch 22, 2022
Press Release Cardiol Therapeutics Appoints Jennifer M. Chao to its Board of DirectorsMarch 15, 2022
View more

2023 Cardiol Therapeutics. All right reserved.